• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov7
UroGen Pharma Reports Q3 Results and Launches ZUSDURI
05:57
Nov6
Urogen Pharma released FY2025 Q3 earnings on November 6 Pre-Market (EST), actual revenue USD 27.48 M (forecast USD 32.47 M), actual EPS USD -0.6938 (forecast USD -0.68)
14:30
Urogen Pharma released FY2025 9-month earnings on November 6 Pre-Market EST, actual revenue USD 71.95 M, actual EPS USD -2.6645
14:30
UroGen Pharmaceuticals Reports Preliminary Results of UGN-103 Clinical Trial
12:58
Oct30
Urogen Pharma to Release FY2025 Q3 Earnings on November 6 Pre-Market EST, Forecast Revenue USD 32.47 M, EPS USD -0.6928
00:08
Oct24
Gershell covers healthcare stocks and gives Urogen Pharma target price
13:32

Schedules & Filings

Schedules
Filings
Nov6
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 27.48 M, Net Income -33.35 M, EPS -0.6938

Aug7
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 24.22 M, Net Income -49.94 M, EPS -1.046

May12
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 20.25 M, Net Income -43.84 M, EPS -0.9245

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
ASPC
24.010
+78.91%
+10.590
PCLA
0.4050
+74.49%
+0.173
DTCK
0.3951
+66.08%
+0.157
SOPA
1.820
+58.26%
+0.670
ECDA
1.150
+46.50%
+0.365
GAUZ
1.470
+44.12%
+0.450
CELG.RT
0.0698
+39.60%
+0.020
ASPCR
0.2500
+38.89%
+0.070
PAVS
2.170
+37.34%
+0.590
CUE
0.3248
+34.77%
+0.084
View More